SCHEMBL730816

SCHEMBL730816

COC(=O)c1cc(OS(=O)(=O)C(F)(F)F)c(Br)c(OS(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.48
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PDK2 Q15119 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ALPL P05186 2/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
NFKB1 P19838 1/20 0.39
XDH P47989 1/20 0.39
GFER P55789 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
FUT7 Q11130 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730998 0.96 NOTUM (0.44) NOTUMKDM4EALDH1A1PDK2CA12
SCHEMBL730724 0.92 LMNA (0.45) NOTUMKDM4EALDH1A1PDK2CA12
SCHEMBL14151101 0.85 NOTUM (0.43) NOTUMKDM4EALDH1A1PDK2CA12
SCHEMBL14448997 0.82 NOTUM (0.47) NOTUMKDM4EALDH1A1PDK2CA12
SCHEMBL25977472 0.82 THRB (0.46) NOTUMKDM4EALDH1A1LMNATSHR
SCHEMBL22026532 0.82 TSHR (0.47) NOTUMKDM4EALDH1A1PDK2LMNA
SCHEMBL24857231 0.82 TPMT (0.44) NOTUMKDM4EALDH1A1CA12CA1
SCHEMBL2469383 0.81 NOTUM (0.57) NOTUMKDM4EALDH1A1PDK2CA12
SCHEMBL14150105 0.81 KDM4E (0.41) NOTUMKDM4EALDH1A1CA12CA1
SCHEMBL4391166 0.81 NOTUM (0.45) NOTUMKDM4EALDH1A1PDK2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 NOTUM 4773/4885KDM4E 3445/4885ALDH1A1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.